News & Events

You are here

Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orlando to meet with Investigators and biotech clients.


Novotech CRO sees changing landscape in Hemato-Oncology at ASH 2019

Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orlando to meet with Investigators and biotech clients. Biotechnology companies are increasingly looking at running Hemato-Oncology clinical trials in...


Novotech and PPC Group Announce Strategic Partnership

Partnership Creates Region’s Largest Biotech CRO Platform to Meet Demand for Clinical Trials in Asia-Pacific

SYDNEY and SHANGHAI, 4 December 2019 – Novotech and PPC Group (PPC), two leading,...






Novotech’s Clinical Network Services wins GENE Awards for Industry excellence in biotech drug development consulting

Clinical Network Services, a subsidiary of Novotech, the Asia-Pacific CRO, was awarded a prestigious GENE Award for Industry Excellence during a ceremony last week.

The award recognizes Clinical Network Services and its consulting division...


Novotech discusses biotechnology CRO services at leadership meeting in Malaysia

Novotech is a full service CRO, offering CRO services across all the Asia-Pacific region with operations in Greater China, Malaysia, Singapore, Thailand, India and South Korea.

“Novotech has presence in every Asian country....


Asia-Pacific shows higher patient recruitment rates for Oncology clinical trials

Biotechnology companies are facing tremendous challenges around patient recruitment, lengthy timeframes and high trial costs.

Asia-Pacific has become a preferred location for clinical studies because of lower trial density, large pools of...


Ovarian cancer landscape in the Asia-Pacific region


Novotech discusses biotech clinical development plans in Asia and Australia at OCT conference in Boston

We’re in Boston and we are seeing tremendous interest from US biotechs in conducting their trials in Asia-pacific. With the cost of researching new...


Novotech sees increased interest from US biotechs in Asia-pacific at OCT Southern California in La Jolla

Novotech is focused on serving the biotech sector in the Asia Pacific region, we work with the most innovative part of the biopharmaceutical sector, in the most diverse and fast growth clinical trial region in the world....


Biotech Funding and Clinical Trial Activities Are Shifting

Despite some recent consolidation, the funding of biotech companies remains strong in 2019. Driven by an increase in sponsors requiring larger studies, the Asia-Pacific region has become a key location to both extend global trials and to...